Literature DB >> 30803762

Age- and sex-dependent profiles of APP fragments and key secretases align with changes in despair-like behavior and cognition in young APPSwe/Ind mice.

Maa O Quartey1, Jennifer N K Nyarko1, Paul R Pennington1, Ryan M Heistad1, Bradley M Chaharyn1, Zelan Wei1, Dennis Bainbridge1, Glen B Baker2, Darrell D Mousseau3.   

Abstract

Biological sex exerts distinct influences on brain levels of the β-amyloid (Aβ) peptide in both clinical depression and Alzheimer disease (AD), yet studies in animal models focus primarily on males. We examined behavioral 'despair'/depression (using the tail-suspension test) and memory (using the novel object recognition task) in J20 (hAPPSwe/Ind) mice. Three month-old male (but not female) J20 mice exhibited less despair-like behavior, but more evidence of cognitive deficits. In young J20 mice, only soluble Aβ peptides -primarily Aβ(1-40)- were detected. There was no evidence of an effect on despair-like behavior in the six month-old J20 mice, although cognitive deficits were now evident in both sexes, and coincided with a greater proportion of the neurotoxic Aβ(1-42) species (in soluble as well as insoluble fractions). This age-dependent shift in Aβ peptide profile coincided with reduced expression of glycosylated species of ADAM-10 (α-secretase) and BACE1 (β-secretase), and an increased co-immunoprecipitation of presenilin-1 with nicastrin (components of the γ-secretase complex). Sex-dependent changes in depression-related monoaminergic, e.g. serotonin and dopamine (but not noradrenaline), systems were evident already in young J20 mice. It is critical to acknowledge that sex-dependent APP-related phenotypes might differentially influence modifiable depression-related monoaminergic signalling at some of the earliest pathological stages of clinical AD.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer; Amyloid; Cortex; Depression; GABA; Monoamines; Sexual dimorphism

Year:  2019        PMID: 30803762     DOI: 10.1016/j.bbrc.2019.02.083

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Magnetic resonance elastography to study the effect of amyloid plaque accumulation in a mouse model.

Authors:  Miklos Palotai; Katharina Schregel; Navid Nazari; Julie P Merchant; Walter M Taylor; Charles R G Guttmann; Ralph Sinkus; Tracy L Young-Pearse; Samuel Patz
Journal:  J Neuroimaging       Date:  2022-04-05       Impact factor: 2.324

2.  Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer's Disease.

Authors:  Charleine Zussy; Rijo John; Théo Urgin; Léa Otaegui; Claire Vigor; Niyazi Acar; Geoffrey Canet; Mathieu Vitalis; Françoise Morin; Emmanuel Planel; Camille Oger; Thierry Durand; Shinde L Rajshree; Laurent Givalois; Padma V Devarajan; Catherine Desrumaux
Journal:  Antioxidants (Basel)       Date:  2022-04-25

3.  The Aβ(1-38) peptide is a negative regulator of the Aβ(1-42) peptide implicated in Alzheimer disease progression.

Authors:  Maa O Quartey; Jennifer N K Nyarko; Jason M Maley; Jocelyn R Barnes; Maria A C Bolanos; Ryan M Heistad; Kaeli J Knudsen; Paul R Pennington; Josef Buttigieg; Carlos E De Carvalho; Scot C Leary; Matthew P Parsons; Darrell D Mousseau
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

4.  Hippocampal Neurogenesis Is Enhanced in Adult Tau Deficient Mice.

Authors:  Marangelie Criado-Marrero; Jonathan J Sabbagh; Margaret R Jones; Dale Chaput; Chad A Dickey; Laura J Blair
Journal:  Cells       Date:  2020-01-14       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.